Aging, methylation and cancer

Nita Ahuja, J. P J Issa

Research output: Contribution to journalArticle

Abstract

Alterations in methylation are widespread in cancers. DNA methylation of promoter-associated CpG islands is an alternate mechanism to mutation in silencing gene function, and affects tumor-suppressor genes such as p16 and RB1, growth and differentiation controlling genes such as ER and many others. Evidence is now accumulating that some of these methylation changes may initiate in subpopulations of normal cells as a function of age and progressively increase during carcinogenesis. Age-related methylation appears to be widespread and is one of the earliest changes marking the risk for neoplasia. In colon cancer, we have shown a pattern of age-related methylation for several genes, including ER, IGF2, N33 and MyoD, which progresses to full methylation in adenomas and neoplasms. Hypermethylation of these genes is associated with gene silencing. Age-related methylation involves at least 50% of the genes which are hypermethylated in colon cancer, and we propose that such age-related methylation may partly account for the fact that most cancers occur as a function of old age. Age-related methylation, then, may be a fundamental mark of the field defect in patients with neoplasia. The causes of age-related methylation are still unknown at this point, but evidence points to an interplay between local predisposing factors in DNA (methylation centers), levels of gene expression and environmental exposure. The concept that age-related methylation is a predisposing factor for neoplasia implies that it may serve as a diagnostic risk marker in cancer, and as a novel target for chemoprevention. Studies in animal models support this hypothesis and should lead to novel approaches to risk-assessment and chemoprevention in humans.

Original languageEnglish (US)
Pages (from-to)835-842
Number of pages8
JournalHistology and Histopathology
Volume15
Issue number3
StatePublished - 2000
Externally publishedYes

Fingerprint

Methylation
Neoplasms
Chemoprevention
Gene Silencing
DNA Methylation
Causality
Colonic Neoplasms
Genes
CpG Islands
Environmental Exposure
Tumor Suppressor Genes
Adenoma
Carcinogenesis
Animal Models
Gene Expression
Mutation
Growth

Keywords

  • Age-related methylation
  • Colorectal cancer
  • CpG islands
  • DNA methylation
  • Tumor-suppressor genes

ASJC Scopus subject areas

  • Anatomy
  • Pathology and Forensic Medicine
  • Histology
  • Cell Biology

Cite this

Ahuja, N., & Issa, J. P. J. (2000). Aging, methylation and cancer. Histology and Histopathology, 15(3), 835-842.

Aging, methylation and cancer. / Ahuja, Nita; Issa, J. P J.

In: Histology and Histopathology, Vol. 15, No. 3, 2000, p. 835-842.

Research output: Contribution to journalArticle

Ahuja, N & Issa, JPJ 2000, 'Aging, methylation and cancer', Histology and Histopathology, vol. 15, no. 3, pp. 835-842.
Ahuja, Nita ; Issa, J. P J. / Aging, methylation and cancer. In: Histology and Histopathology. 2000 ; Vol. 15, No. 3. pp. 835-842.
@article{fcec3a3714ac458e8faf8457c7f1ca81,
title = "Aging, methylation and cancer",
abstract = "Alterations in methylation are widespread in cancers. DNA methylation of promoter-associated CpG islands is an alternate mechanism to mutation in silencing gene function, and affects tumor-suppressor genes such as p16 and RB1, growth and differentiation controlling genes such as ER and many others. Evidence is now accumulating that some of these methylation changes may initiate in subpopulations of normal cells as a function of age and progressively increase during carcinogenesis. Age-related methylation appears to be widespread and is one of the earliest changes marking the risk for neoplasia. In colon cancer, we have shown a pattern of age-related methylation for several genes, including ER, IGF2, N33 and MyoD, which progresses to full methylation in adenomas and neoplasms. Hypermethylation of these genes is associated with gene silencing. Age-related methylation involves at least 50{\%} of the genes which are hypermethylated in colon cancer, and we propose that such age-related methylation may partly account for the fact that most cancers occur as a function of old age. Age-related methylation, then, may be a fundamental mark of the field defect in patients with neoplasia. The causes of age-related methylation are still unknown at this point, but evidence points to an interplay between local predisposing factors in DNA (methylation centers), levels of gene expression and environmental exposure. The concept that age-related methylation is a predisposing factor for neoplasia implies that it may serve as a diagnostic risk marker in cancer, and as a novel target for chemoprevention. Studies in animal models support this hypothesis and should lead to novel approaches to risk-assessment and chemoprevention in humans.",
keywords = "Age-related methylation, Colorectal cancer, CpG islands, DNA methylation, Tumor-suppressor genes",
author = "Nita Ahuja and Issa, {J. P J}",
year = "2000",
language = "English (US)",
volume = "15",
pages = "835--842",
journal = "Histology and Histopathology",
issn = "0213-3911",
publisher = "Histology and Histopathology",
number = "3",

}

TY - JOUR

T1 - Aging, methylation and cancer

AU - Ahuja, Nita

AU - Issa, J. P J

PY - 2000

Y1 - 2000

N2 - Alterations in methylation are widespread in cancers. DNA methylation of promoter-associated CpG islands is an alternate mechanism to mutation in silencing gene function, and affects tumor-suppressor genes such as p16 and RB1, growth and differentiation controlling genes such as ER and many others. Evidence is now accumulating that some of these methylation changes may initiate in subpopulations of normal cells as a function of age and progressively increase during carcinogenesis. Age-related methylation appears to be widespread and is one of the earliest changes marking the risk for neoplasia. In colon cancer, we have shown a pattern of age-related methylation for several genes, including ER, IGF2, N33 and MyoD, which progresses to full methylation in adenomas and neoplasms. Hypermethylation of these genes is associated with gene silencing. Age-related methylation involves at least 50% of the genes which are hypermethylated in colon cancer, and we propose that such age-related methylation may partly account for the fact that most cancers occur as a function of old age. Age-related methylation, then, may be a fundamental mark of the field defect in patients with neoplasia. The causes of age-related methylation are still unknown at this point, but evidence points to an interplay between local predisposing factors in DNA (methylation centers), levels of gene expression and environmental exposure. The concept that age-related methylation is a predisposing factor for neoplasia implies that it may serve as a diagnostic risk marker in cancer, and as a novel target for chemoprevention. Studies in animal models support this hypothesis and should lead to novel approaches to risk-assessment and chemoprevention in humans.

AB - Alterations in methylation are widespread in cancers. DNA methylation of promoter-associated CpG islands is an alternate mechanism to mutation in silencing gene function, and affects tumor-suppressor genes such as p16 and RB1, growth and differentiation controlling genes such as ER and many others. Evidence is now accumulating that some of these methylation changes may initiate in subpopulations of normal cells as a function of age and progressively increase during carcinogenesis. Age-related methylation appears to be widespread and is one of the earliest changes marking the risk for neoplasia. In colon cancer, we have shown a pattern of age-related methylation for several genes, including ER, IGF2, N33 and MyoD, which progresses to full methylation in adenomas and neoplasms. Hypermethylation of these genes is associated with gene silencing. Age-related methylation involves at least 50% of the genes which are hypermethylated in colon cancer, and we propose that such age-related methylation may partly account for the fact that most cancers occur as a function of old age. Age-related methylation, then, may be a fundamental mark of the field defect in patients with neoplasia. The causes of age-related methylation are still unknown at this point, but evidence points to an interplay between local predisposing factors in DNA (methylation centers), levels of gene expression and environmental exposure. The concept that age-related methylation is a predisposing factor for neoplasia implies that it may serve as a diagnostic risk marker in cancer, and as a novel target for chemoprevention. Studies in animal models support this hypothesis and should lead to novel approaches to risk-assessment and chemoprevention in humans.

KW - Age-related methylation

KW - Colorectal cancer

KW - CpG islands

KW - DNA methylation

KW - Tumor-suppressor genes

UR - http://www.scopus.com/inward/record.url?scp=0033913645&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033913645&partnerID=8YFLogxK

M3 - Article

C2 - 10963127

AN - SCOPUS:0033913645

VL - 15

SP - 835

EP - 842

JO - Histology and Histopathology

JF - Histology and Histopathology

SN - 0213-3911

IS - 3

ER -